University of Toronto researchers used the Canadian Light Source synchrotron, Canada’s only device of its kind, to develop medicinal compounds capable of fighting antibiotic-resistant bacteria.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback